Exact Sciences
EXAS
#1781
Rank
ยฃ7.28 B
Marketcap
ยฃ39.37
Share price
-2.28%
Change (1 day)
-18.77%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ2.52 Billion

According to Exact Sciences's latest financial reports the company has ยฃ2.52 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ2.46 B-1.85%
2022-12-31$ยฃ2.51 B0.23%
2021-12-31$ยฃ2.50 B53.02%
2020-12-31$ยฃ1.64 B-6.01%
2019-12-31$ยฃ1.74 B225.27%
2018-12-31$ยฃ0.53 B39.31%
2017-12-31$ยฃ0.38 B41.71%
2016-12-31$ยฃ0.27 B23.2%
2015-12-31$ยฃ0.22 B18.83%
2014-12-31$ยฃ0.18 B126.27%
2013-12-31$ยฃ82.03 M34.48%
2012-12-31$ยฃ61 M13.56%
2011-12-31$ยฃ53.71 M3.98%
2010-12-31$ยฃ51.66 M1271.88%
2009-12-31$ยฃ3.76 M-326.85%
2008-12-31$-ยฃ1.67 Million-152.45%
2007-12-31$ยฃ3.16 M-58.55%
2006-12-31$ยฃ7.63 M-46.51%
2005-12-31$ยฃ14.27 M-27.84%
2004-12-31$ยฃ19.78 M189.43%
2003-12-31$ยฃ6.83 M-71.42%
2002-12-31$ยฃ23.91 M-41.19%
2001-12-31$ยฃ40.66 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ0.58 B-76.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.92 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.22 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ61.42 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France